Pactamycin analogs offer new, gentler approach to cancer treatment

18 mayo 2015

Researchers are pursuing a new concept in treatment of cancer, by using two promising ‘analogs’ of an old compound that was once studied as a potent anti-tumor agent, but long ago abandoned because it was too toxic. The idea is not to kill cancer cells, but rather to put them to sleep – lessening problems with resistance to chemotherapeutic drugs, and also the side effects of chemotherapy.